Notice: Clarifications Regarding Access to Restricted Drugs through the Special Access Program (SAP) (French, HTML)
Notice: Clarifications Regarding Access to Restricted Drugs through the Special Access Program (SAP): French HTML file. From Health Canada, updated Dec 2021. View metadata, licence and the direct download on CanQuery.
- Format
- HTML
- Access
- Original download only
- Publisher-reported update
- 2021-12-29
Drugs are authorized for sale in Canada once they have successfully gone through the drug review process, which includes the assessment of the safety, efficacy and quality of the drug. However, Health Canada's SAP allows practitioners to request access to drugs that are not available in Canada for the emergency treatment of patients with serious or life-threatening conditions who have exhausted other treatment options.
Data overview
- Formats
- HTML
- File languages
- French
- Available actions
- Access original file